Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction - Wikidata - awgldk - TriplyDB

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

http://www.wikidata.org/entity/Q28323972

about

sameAs

Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives)T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1 Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide Identification of novel thiocarboxanilide derivatives that suppress a variety of drug-resistant mutant human immunodeficiency virus type 1 strains at a potency similar to that for wild-type virus Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription 1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase Highly potent oxathiin carboxanilide derivatives with efficacy against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus isolates Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781 Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom.Antiviral therapy for human immunodeficiency virus infections In search of a selective antiviral chemotherapy.A thermodynamic study of the cyclodextrin-UC781 inclusion complex using a HPLC method.Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture.In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission New developments in the chemotherapy of lentivirus (human immunodeficiency virus) infections: sensitivity/resistance of HIV-1 to non-nucleoside HIV-1-specific inhibitors.Inhibition of reverse transcriptase of human immunodeficiency virus type 1 and chimeric enzymes of human immunodeficiency viruses types 1 and 2 by two novel non-nucleoside inhibitors.

P2860

Q28343461-8F455315-AA79-4449-ABAD-DDFB017C57A7 Q28367673-DD3E2455-2DFF-4B9A-BBDD-9AF1F215D692 Q28367704-019D14E2-A9AA-43D1-B857-1C3D4B91BC1D Q28378782-DE422AB1-A1D9-463E-BBCE-D1E3B72F686B Q28378796-C49C43DA-45B1-469C-8E35-DE10C6F5DE58 Q28379002-C1D14206-6C04-42AC-9370-94245E1463B7 Q28379402-5464F70A-003B-4C45-AC28-4C643B62D5AE Q28379406-45E96497-78E2-443F-B455-CB9F90B3E5CB Q28379468-680B2B30-9FB4-4218-8479-02303F438846 Q28379510-2551380F-0DB1-4359-8F10-13D1EAAA8096 Q28379523-D6777B53-82C0-4046-96EB-F6B314D84562 Q33393733-2288E29C-EC70-48E5-B3EF-8F1603C77394 Q33813305-85C5AA5D-D1C4-4852-B763-0432B01F9510 Q35366050-DC2AE32F-3F8E-4B2C-A812-A623E01552E7 Q35375912-033AD28D-EBAE-4FD5-974E-C05B290A718D Q35755988-ADCA6438-5B3A-4B2B-9DDA-172EC1BD9FFF Q35759112-D63AA74C-1624-4049-AFA3-AF22AA576619 Q37568492-5C83599C-F959-41E7-BF99-866EBFB5F9E3 Q40390744-A19D03C3-E37F-4C04-8E9E-A8411D7C05DE Q42275289-95D272B7-E7C7-40BE-B854-02AC23D04319

P2860

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

http://www.wikidata.org/entity/Q28323972

description

1991 nî lūn-bûn

@nan

1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1991 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

name

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

@ast

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

@en

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

@nl

type

label

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

@ast

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

@en

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

@nl

prefLabel

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

@ast

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

@en

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

@nl

P1433

Q28323972-62B81D13-2318-4E79-9F57-7C845FADBD5D

P1476

Q28323972-8813CB9E-6A18-47B5-9C07-A88742C5F236

P2093

Q28323972-1A19AB05-F2A2-450D-80E0-593478CFDC46

Q28323972-2FAD05B4-192F-404A-A83D-B1365434C2A3

Q28323972-33330678-C608-4F93-AF46-7276676CBC4D

Q28323972-58D90673-FD96-468A-9B0C-747E7C9B6800

Q28323972-71D39CEE-DC3A-468B-B78F-4FDD3A233CFE

Q28323972-BB37B0A5-68CE-4B82-9221-1154C0D491F7

Q28323972-D2A9FD57-755F-4AD4-8113-5CB5B8EC4AAD

Q28323972-E8CFA499-732F-4196-90E2-45342AE6A9C9

Q28323972-E9C9685F-11D4-4023-A32D-C236F56B21B4

Q28323972-F731ECEC-5FE3-4A1E-810B-30D9A420DF53

P2860

Q28323972-0B787732-14BA-4BA3-9F14-A482449D4020

Q28323972-1745C702-D0CA-4ED5-8A7C-D3E81D447367

Q28323972-1D6B8960-4744-4C77-9164-009C3327A534

Q28323972-2BA7A4CB-46C5-4D6C-B844-E9118AD76B6A

Q28323972-3A802E23-81BB-405A-B708-5B388B6927BF

Q28323972-3E2EC531-0DB4-4F71-A7B1-EBEB4DCE642A

Q28323972-56BB4F95-F0A9-40B5-9F03-87FB9A6FE722

Q28323972-6DC20C53-6B0A-43D7-BDF0-22C101F33E04

Q28323972-6DDA9A21-EFA8-4373-93A1-82CCA54957C8

Q28323972-962043FD-F464-4CA9-BC0E-6701DBC403E1

P304

Q28323972-F8CA8A62-26A8-4AAF-A328-BDDDA69534AD

P31

Q28323972-2C7A5F3F-189A-4C1F-A3FD-020E209C3E3C

P356

Q28323972-5DE9CC66-002D-4D39-811D-62659F1B6A7C

P407

Q28323972-F12D1218-25A2-4A54-9668-54AB21AEC835

P433

Q28323972-75217431-A5D3-4615-825A-268F4CDEF7DA

P478

Q28323972-CF46562D-85FF-488E-A405-BD0FC63DBF7A

P577

Q28323972-3E7CF00C-875B-42A7-B9FA-3787EE377127

P5875

Q28323972-76D3F8A2-9539-4DA0-A56C-0B0C1B549087

P698

Q28323972-A1EE63D2-01E0-47F8-A266-0F9967FB7DF1

P932

Q28323972-A9232C3B-B116-4D58-AE89-AB17AD85E797

P356

PNAS.88.15.6740

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

@en

P2093

C F Midelfort

http://www.w3.org/2001/XMLSchema#string

J B McMahon

http://www.w3.org/2001/XMLSchema#string

J B Pierce

http://www.w3.org/2001/XMLSchema#string

J P Bader

http://www.w3.org/2001/XMLSchema#string

M R Boyd

http://www.w3.org/2001/XMLSchema#string

O S Weislow

http://www.w3.org/2001/XMLSchema#string

R J Schultz

http://www.w3.org/2001/XMLSchema#string

S F Stinson

http://www.w3.org/2001/XMLSchema#string

V L Narayanan

http://www.w3.org/2001/XMLSchema#string

W A Harrison

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

P304

6740-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.88.15.6740

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

1991-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21441471

http://www.w3.org/2001/XMLSchema#string

P698

1713689

http://www.w3.org/2001/XMLSchema#string

P932

52164

http://www.w3.org/2001/XMLSchema#string